CYSLTR2 and neoplasm: The CYSLTR1 and CYSLTR2 gene expressions and methylation were validated in an additional in silico cohort (E-MTAB), with the transcriptome and genome-wide methylation sequencing for primary tumor and normal samples (Figure 6A–J).